Viewing Study NCT05247957


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-25 @ 4:08 PM
Study NCT ID: NCT05247957
Status: TERMINATED
Last Update Posted: 2023-01-13
First Post: 2022-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Hangzhou Cheetah Cell Therapeutics Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module